RWA
TEVA icon

River Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

River Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-850
Closed -$21K – 609
2018
Q2 		$21K Buy
+850
New +$17.3K 0.01% 350
2017
Q4 		– Sell
-11,398
Closed -$201K – 165
2017
Q3 		$201K Sell
11,398
-14,502
-56% -$326K 0.09% 153
2017
Q2 		$860K Sell
25,900
-2,281
-8% -$70.6K 0.4% 87
2017
Q1 		$904K Sell
28,181
-6,402
-19% -$218K 0.44% 80
2016
Q4 		$1.25M Buy
34,583
+24,709
+250% +$987K 0.63% 61
2016
Q3 		$454K Buy
9,874
+8
+0.1% +$417 0.25% 112
2016
Q2 		$496K Buy
9,866
+757
+8% +$40.3K 0.28% 101
2016
Q1 		$487K Buy
9,109
+257
+3% +$15.1K 0.29% 98
2015
Q4 		$581K Buy
8,852
+796
+10% +$49.2K 0.37% 89
2015
Q3 		$455K Sell
8,056
-296
-4% -$19.2K 0.31% 99
2015
Q2 		$494K Buy
8,352
+429
+5% +$26.5K 0.31% 100
2015
Q1 		$494K Buy
+7,923
New +$461K 0.31% 103

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

River Wealth Advisors's TEVA Position: Q3 2018 in Review

River Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2018, closing a stake of 850 shares — an estimated $21K sold.

River Wealth Advisors first reported a position in TEVA in Q1 2015 and held it in 12 quarters. The position peaked at $1.25M in Q4 2016. 557 funds tracked by Wall St. Rank hold TEVA as of Q3 2018.

  • River Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • River Wealth Advisors sold 850 Teva Pharmaceuticals shares in Q3 2018, an estimated $21K.
  • River Wealth Advisors first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 12 quarters.
  • River Wealth Advisors's Teva Pharmaceuticals position peaked at $1.25M in Q4 2016.
  • 557 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2018.

Based on River Wealth Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.